GlassScriptPhysician profile
April Lynn Diep
NPI 1871933895
$364.95
in general payments reported to CMS, 2019-2025
12 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.95 · 2020: $39.35 · 2021: $11.39 · 2023: $76.73 · 2024: $36.98 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $69.50 | 2023-2025 | Mounjaro, Zepbound, Kisunla |
| Pfizer INC. | $53.95 | 2019-2020 | |
| Exact Sciences Corporation | $51.72 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $47.67 | 2024-2025 | Veozah |
| Dynavax Technologies Corporation | $25.61 | 2023 | Heplisav-B |
| Abbvie INC. | $22.26 | 2024 | |
| Glaxosmithkline, LLC. | $21.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.25 | 2019 | |
| Currax Pharmaceuticals LLC | $14.38 | 2025 | Contrave |
| Novo Nordisk INC | $14.12 | 2023 | Wegovy |
| Therapeuticsmd, INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Diep listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.